CSIMarket
 


Avid Bioservices Inc   (CDMO)
Other Ticker:  
 
 

CDMO's Net Income Growth by Quarter and Year

Avid Bioservices Inc 's Net Income results by quarter and year




CDMO Net Income (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter April - -0.31 115.60 1.99
III Quarter January - 0.46 2.25 2.21
II Quarter October -9.51 -1.16 3.52 2.28
I Quarter July -2.09 1.56 6.30 4.73
FY   -11.60 0.55 127.67 11.21



CDMO Net Income second quarter 2024 Y/Y Growth Comment
Avid Bioservices Inc in the second quarter 2024 recorded net loss of $ -9.51 millions.

Looking into second quarter 2024 results within Major Pharmaceutical Preparations industry 15 other companies have achieved higher Net Income growth. While Avid Bioservices Inc ' s Net Income no change of % ranks overall at the positon no. 1086 in the second quarter 2024.




CDMO Net Income ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter April - - 5709.05 % -
III Quarter January - -79.56 % 1.81 % -
II Quarter October - - 54.39 % -
I Quarter July - -75.24 % 33.19 % -
FY   - -99.57 % 1038.89 % -

Financial Statements
Avid Bioservices Inc 's second quarter 2024 Net Income $ -9.51 millions CDMO's Income Statement
Avid Bioservices Inc 's second quarter 2023 Net Income $ -1.16 millions Quarterly CDMO's Income Statement
New: More CDMO's historic Net Income Growth >>


CDMO Net Income (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter April - - 5037.78 % -9.95 %
III Quarter January - - -36.08 % -3.07 %
II Quarter October - - -44.13 % -51.8 %
I Quarter July - -98.65 % 216.58 % -
FY (Year on Year)   - -99.57 % 1038.89 % -




Net Income second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #16
Healthcare Sector #75
Overall #1086

Net Income Y/Y Growth Statistics
High Average Low
9776.06 % 1450.18 % -109.68 %
(Oct 31 2021)   (Oct 31 2023)
Net Income second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #16
Healthcare Sector #75
Overall #1086
Net Income Y/Y Growth Statistics
High Average Low
9776.06 % 1450.18 % -109.68 %
(Oct 31 2021)   (Oct 31 2023)

Net Income by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Avid Bioservices Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CDMO's II. Quarter Q/Q Net Income Comment
II. Quarter 2024 net loss of -9.51 millions by Avid Bioservices Inc look even more unfavourable if you take a look at -2.09 millions net loss a quarter before.

Within Major Pharmaceutical Preparations industry Avid Bioservices Inc achieved highest sequential Net Income growth. While Avid Bioservices Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CDMO's II. Quarter Q/Q Net Income Comment
II. Quarter 2024 accomplishment of -9.51 millions by Avid Bioservices Inc come out even worse if you take a look at -2.09 millions net loss a quarter before.

Within Major Pharmaceutical Preparations industry Avid Bioservices Inc achieved highest sequential Net Income growth. While Avid Bioservices Inc 's Net Income growth quarter on quarter, overall rank is .


Avid Bioservices Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Oct 31 2023)
12 Months Ending
(Jul 31 2023)
12 Months Ending
(Apr 30 2023)
12 Months Ending
(Jan 31 2023)
12 Months Ending
(Oct 31 2022)
Cumulative Net Income 12 Months Ending $ -11.45 $ -3.10 $ 0.56 $ 116.47 $ 118.25
Y / Y Net Income Growth (TTM) - - -99.56 % 728.06 % 743.23 %
Year on Year Net Income Growth Overall Ranking # 45 # 30 # 33 # 3 # 44
Seqeuential Net Income Change (TTM) - - -99.52 % -1.51 % -3.81 %
Seq. Net Income Growth (TTM) Overall Ranking # 1086 # 1178 # 42 # 719 # 1553




Cumulative Net Income growth Comment
Avid Bioservices Inc realized trailing twelve months net loss of $ -11 millions, in the Oct 31 2023, compare to Net Income of $ 118 millions a year ago.

Among companies within the Healthcare sector 2 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 30 to 45.

Net Income TTM Q/Q Growth Statistics
High Average Low
9776.06 %
1450.18 %
-109.68 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 16
Healthcare Sector # 3
Overall # 45

Net Income TTM Y/Y Growth Statistics
High Average Low
9776.06 %
1450.18 %
-109.68 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 16
Sector # 75
S&P 500 # 1086
Cumulative Net Income growth Comment
Avid Bioservices Inc realized trailing twelve months net loss of $ -11 millions, in the Oct 31 2023, compare to Net Income of $ 118 millions a year ago.

Among companies within the Healthcare sector 2 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 30 to 45.

Net Income TTM Q/Q Growth Statistics
High Average Low
9776.06 %
1450.18 %
-109.68 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 16
Healthcare Sector # 3
Overall # 45

Net Income TTM Y/Y Growth Statistics
High Average Low
9776.06 %
1450.18 %
-109.68 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 16
Sector # 75
S&P 500 # 1086




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
CDMO's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for CDMO's Competitors
Net Income Growth for Avid Bioservices Inc 's Suppliers
Net Income Growth for CDMO's Customers

You may also want to know
CDMO's Annual Growth Rates CDMO's Profitability Ratios CDMO's Asset Turnover Ratio CDMO's Dividend Growth
CDMO's Roe CDMO's Valuation Ratios CDMO's Financial Strength Ratios CDMO's Dividend Payout Ratio
CDMO's Roa CDMO's Inventory Turnover Ratio CDMO's Growth Rates CDMO's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Oct 31 2023 within Healthcare SectorY/Y Change %Net Income for the quarter ending Oct 31 2023
Johnson and Johnson483.85%$ 483.849 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com